NEW YORK (GenomeWeb News) — Cepheid said today that it has received CE marking for Xpert Flu/RSV XC, an on-demand molecular test for determination of influenza A and B infection and differentiation of respiratory syncytial virus infection.

The new test runs on Cepheid's GeneXpert system, of which more than 7,000 are installed worldwide, Cepheid said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.